New monthly injection aims to tame acromegaly safely
Disease control
Completed
This study tested a monthly injection called CAM2029 (octreotide) in 135 adults with acromegaly, a condition where the body makes too much growth hormone. The goal was to see if the drug is safe and keeps hormone levels under control over 12 months. Participants had already been …
Phase: PHASE3 • Sponsor: Camurus AB • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC